Background: Serum uric acid (UA) is increasingly recognized as a cardiovascular (CV) risk factor, with evidence suggesting that CV risk may occur at levels below conventional hyperuricemia thresholds. However, real-world comparative data on the effects of dietary interventions on UA are limited. Objective: The primary objective of this study was to compare the effects of a very low-calorie ketogenic diet (VLCKD), intermittent fasting (IF), and standard dietary advice (free diet, FD) on UA levels and UA-defined CV risk in hypertensive postmenopausal women. Methods: In this prospective, single-center, real-world clinical study, 43 women with essential hypertension and obesity underwent dietary interventions. UA levels were assessed at baseline and after 6 months. Hyperuricemia was defined using both the conventional threshold (≥6.0 mg/dL) and the CV risk-oriented Uric Acid Right for Heart Health (URRAH) cut-off (≥4.7 mg/dL). Analyses included paired tests and ANCOVA adjusted for baseline UA. Results: At baseline, over half of participants exceeded the URRAH threshold. Only VLCKD significantly reduced UA levels (-1.23 mg/dL; p < 0.001), remaining independently associated after adjustment (β = -0.95 mg/dL; p = 0.007). URRAH-defined CV risk decreased significantly only in the VLCKD group (55.6% to 22.2%), with one-third transitioning to lower risk. Conclusions: VLCKD significantly reduced UA levels and UA-defined CV risk, supporting its role as a potentially effective lifestyle intervention in this population.

Serum uric acid as a cardiovascular risk marker: differential effects of ketogenic diet and intermittent fasting in postmenopausal women / Pala, B., Pennazzi, L., Piscione, M., Nardoianni, G., Miletti, G., De Mitri, S., Gualtieri, P., Di Renzo, L., Barbato, E., Tocci, G.. - In: NUTRIENTS. - ISSN 2072-6643. - 18:12(2026), pp. 1-17. [10.3390/nu18121912]

Serum uric acid as a cardiovascular risk marker: differential effects of ketogenic diet and intermittent fasting in postmenopausal women

Nardoianni, Giulia;Miletti, Gemma;Barbato, Emanuele;Tocci, Giuliano
2026

Abstract

Background: Serum uric acid (UA) is increasingly recognized as a cardiovascular (CV) risk factor, with evidence suggesting that CV risk may occur at levels below conventional hyperuricemia thresholds. However, real-world comparative data on the effects of dietary interventions on UA are limited. Objective: The primary objective of this study was to compare the effects of a very low-calorie ketogenic diet (VLCKD), intermittent fasting (IF), and standard dietary advice (free diet, FD) on UA levels and UA-defined CV risk in hypertensive postmenopausal women. Methods: In this prospective, single-center, real-world clinical study, 43 women with essential hypertension and obesity underwent dietary interventions. UA levels were assessed at baseline and after 6 months. Hyperuricemia was defined using both the conventional threshold (≥6.0 mg/dL) and the CV risk-oriented Uric Acid Right for Heart Health (URRAH) cut-off (≥4.7 mg/dL). Analyses included paired tests and ANCOVA adjusted for baseline UA. Results: At baseline, over half of participants exceeded the URRAH threshold. Only VLCKD significantly reduced UA levels (-1.23 mg/dL; p < 0.001), remaining independently associated after adjustment (β = -0.95 mg/dL; p = 0.007). URRAH-defined CV risk decreased significantly only in the VLCKD group (55.6% to 22.2%), with one-third transitioning to lower risk. Conclusions: VLCKD significantly reduced UA levels and UA-defined CV risk, supporting its role as a potentially effective lifestyle intervention in this population.
2026
URRAH; cardiovascular risk; dietary intervention; hypertension; intermittent fasting; ketogenic diet; metabolic risk; postmenopausal women; serum uric acid
01 Pubblicazione su rivista::01a Articolo in rivista
Serum uric acid as a cardiovascular risk marker: differential effects of ketogenic diet and intermittent fasting in postmenopausal women / Pala, B., Pennazzi, L., Piscione, M., Nardoianni, G., Miletti, G., De Mitri, S., Gualtieri, P., Di Renzo, L., Barbato, E., Tocci, G.. - In: NUTRIENTS. - ISSN 2072-6643. - 18:12(2026), pp. 1-17. [10.3390/nu18121912]
File allegati a questo prodotto
File Dimensione Formato  
Pala_Serum_2026.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 830.16 kB
Formato Adobe PDF
830.16 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1770377
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact